These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3097754)

  • 1. Metabolites of antiarrhythmic drugs: are they clinically important?
    Kates RE
    Ration Drug Ther; 1986 May; 20(5):1-5. PubMed ID: 3097754
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacokinetics of antiarrhythmic drugs.
    Harrison DC; Meffin PJ; Winkle RA
    Prog Cardiovasc Dis; 1977; 20(3):217-42. PubMed ID: 335439
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of old and new antiarrhythmic drugs.
    Siddoway LA; Roden DM; Woosley RL
    Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
    Atarashi H; Hayakawa H
    Nihon Rinsho; 1985 Nov; 43(11):2422-7. PubMed ID: 3936948
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Series on pharmacology in practice. 2. Antiarrhythmic drug therapy.
    Federman J; Vlietstra RE
    Mayo Clin Proc; 1979 Aug; 54(8):531-42. PubMed ID: 459565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic drugs.
    Roy D
    Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S65-7. PubMed ID: 2872953
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolites of cardiac antiarrhythmic drugs: their clinical role.
    Kates RE
    Ann N Y Acad Sci; 1984; 432():75-89. PubMed ID: 6441496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
    Woosley RL; Echt DS; Roden DM
    Am J Cardiol; 1986 Jan; 57(3):25B-33B. PubMed ID: 3080860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic therapy: new additions and future expectations.
    Ross WB; Mohiuddin SM
    Geriatrics; 1983 Jan; 38(1):30-5. PubMed ID: 6184263
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
    Anderson JL
    Am J Cardiol; 1990 Feb; 65(8):32D-40D. PubMed ID: 2106254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
    Nestico PF; DePace NL; Morganroth J
    Med Clin North Am; 1984 Sep; 68(5):1295-319. PubMed ID: 6436595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of metabolites in antiarrhythmic therapy.
    Woosley RL; Roden DM
    Am J Cardiol; 1983 Sep; 52(6):3C-7C. PubMed ID: 6194679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.